Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Repurchased: 985,000 ordinary shares of 25 pence each.
- Repurchase Date: August 15, 2011.
- Price Range: Highest price paid was 1,288.5 pence per share; lowest price paid was 1,275.5 pence per share.
- Treasury Shares Held: 502,996,816 shares (representing 8.99% of total issued share capital and 9.88% of total voting rights).
- Shares in Issue: 5,093,182,623 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's issued share capital through the cancellation of 985,000 repurchased shares. Consequently, the total number of shares in issue decreased, while the proportion of Treasury shares relative to total voting rights increased to 9.88%.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of specific risks and contingencies. It is a compliance disclosure confirming adherence to the Financial Services Authority's Disclosure and Transparency Rules regarding share buybacks.
Key Facts for Investor Verification
- Verify the total cost of the repurchase by calculating the weighted average price of the 985,000 shares bought between 1,275.5 and 1,288.5 pence.
- Confirm the updated total issued share capital and the specific impact on earnings per share (EPS) following the cancellation of these shares.
- Review the remaining authorization for share buybacks under the mandate approved on May 5, 2011, to assess future capital return potential.
- Check the current market price of GSK shares against the repurchase price range to evaluate the timing of the buyback.